• Home
  • News

Sichenzia Ross Ference LLP Represents Biotricity Inc. in a $6 Million Private Placement of its Series A Convertible Preferred Stock

biotricity logo

Press Release – New York, New York – December 19, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, in connection with the sale of $6M of its Series A convertible preferred stock.

The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia and David Manno.